Search Results

There are 19350 results for: content related to: Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone

  1. You have free access to this content
    Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 966–973, Nicholas D. James, Armelle Caty, Heather Payne, Michael Borre, Bernard A. Zonnenberg, Philippe Beuzeboc, Stuart McIntosh, Thomas Morris, De Phung and Nancy A. Dawson

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09638.x

  2. You have free access to this content
    Role of the endothelin axis and its antagonists in the treatment of cancer

    British Journal of Pharmacology

    Volume 163, Issue 2, May 2011, Pages: 220–233, A Bagnato, M Loizidou, BR Pflug, J Curwen and J Growcott

    Version of Record online : 18 APR 2011, DOI: 10.1111/j.1476-5381.2011.01217.x

  3. You have free access to this content
    Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  4. You have free access to this content
    Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  5. You have free access to this content
    IMPROVED SURVIVAL PROSPECTS FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

    BJU International

    Volume 107, Issue 5, March 2011, Pages: 697–700, Roger S. Kirby and John M. Fitzpatrick

    Version of Record online : 11 FEB 2011, DOI: 10.1111/j.1464-410X.2010.10027.x

  6. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  7. Emerging treatment options for patients with castration-resistant prostate cancer

    The Prostate

    Volume 72, Issue 3, February 2012, Pages: 338–349, Daniel George and Judd W. Moul

    Version of Record online : 11 JUL 2011, DOI: 10.1002/pros.21435

  8. Targeted therapy in prostate cancer

    Histopathology

    Volume 60, Issue 1, January 2012, Pages: 216–231, Niall M Corcoran and Martin E Gleave

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1365-2559.2011.04030.x

  9. Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer

    The Prostate

    Volume 71, Issue 12, September 2011, Pages: 1264–1275, Donald L. Trump, Heather Payne, Kurt Miller, Johann S. de Bono, Joe Stephenson III, Howard A. Burris III, Faith Nathan, Maria Taboada, Thomas Morris and Andreas Hubner

    Version of Record online : 26 JAN 2011, DOI: 10.1002/pros.21342

  10. You have free access to this content
    Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer

    International Journal of Cancer

    Volume 133, Issue 7, 1 October 2013, Pages: 1743–1750, Ning Shao, Yang Wang, Wen Yu Jiang, Di Qiao, Shi Ge Zhang, Ye Wu, Xiang Xiang Zhang, Jiu Ling Wang, Yi Ding and Ning Han Feng

    Version of Record online : 8 APR 2013, DOI: 10.1002/ijc.28162

  11. You have free access to this content
    Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Version of Record online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  12. You have full text access to this OnlineOpen article
    Targeting the adaptive molecular landscape of castration-resistant prostate cancer

    EMBO Molecular Medicine

    Volume 7, Issue 7, July 2015, Pages: 878–894, Alexander W Wyatt and Martin E Gleave

    Version of Record online : 20 APR 2015, DOI: 10.15252/emmm.201303701

  13. You have free access to this content
    Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival

    BJU International

    Volume 114, Issue 6b, December 2014, Pages: E70–E73, Campbell Tait, David Moore, Clare Hodgson, Michael Brown, Thomas Morris, Jim Growcott, Michael Malone, Andrew Hughes, Andrew Renehan, Noel W. Clarke and Caroline Dive

    Version of Record online : 27 JUL 2014, DOI: 10.1111/bju.12717

  14. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Version of Record online : 24 APR 2012, DOI: 10.3322/caac.21141

  15. You have free access to this content
    Advanced prostate cancer – lessons from the past for success in the future

    Trends in Urology & Men's Health

    Volume 3, Issue 3, May/June 2012, Pages: 36–40, Karim Fizazi, Heather A. Payne and John Staffurth

    Version of Record online : 24 MAY 2012, DOI: 10.1002/tre.268

  16. Zibotentan

    Standard Article

    Handbook of Metabolic Pathways of Xenobiotics

    Xin Zhou

    Published Online : 1 OCT 2014, DOI: 10.1002/9781118541203.xen374

  17. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  18. You have free access to this content
    SPECIFIC ENDOTHELIN-A RECEPTOR ANTAGONISM FOR THE TREATMENT OF ADVANCED PROSTATE CANCER

    BJU International

    Volume 104, Issue 10, November 2009, Pages: 1423–1425, Karim Fizazi and Kurt Miller

    Version of Record online : 14 JUL 2009, DOI: 10.1111/j.1464-410X.2009.08740.x

  19. You have free access to this content
    Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E82–E89, Alessandro Tenuta, Laurence Klotz and Jayson L. Parker

    Version of Record online : 2 DEC 2013, DOI: 10.1111/bju.12309

  20. You have free access to this content
    Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor-directed therapies

    Cancer

    Volume 121, Issue 3, February 1, 2015, Pages: 361–371, Won Kim and Charles J. Ryan

    Version of Record online : 18 SEP 2014, DOI: 10.1002/cncr.28929